CIK 0001701108 · Non-accelerated filer<br>Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $42,485
- in 1 filing
Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 95 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-05 | Shukla Sath CEO and President | Sale | −17,641 | $1.31 | $23K | 1,143,566 |
| 2024-08-02 | Shukla Sath CEO and President | Sale | −14,800 | $1.32 | $20K | 1,161,207 |
| 2024-05-29 | Deshpande Milind Director | Grant or award | +20,000 | 71,454 | ||
| 2024-05-29 | Jackson Scott Thomas Director | Grant or award | +20,000 | 55,000 | ||
| 2024-05-29 | Mahadevia Ankit Director | Grant or award | +20,000 | 764,997 | ||
| 2024-05-29 | Tregoning Kathleen Director | Grant or award | +20,000 | 55,000 | ||
| 2024-05-29 | VINK PATRICK V.J.J. Director | Grant or award | +20,000 | 55,000 | ||
| 2024-05-29 | Smith Cynthia Director | Grant or award | +20,000 | 55,000 | ||
| 2024-05-29 | THOMAS FRANK E Director | Grant or award | +20,000 | 55,000 | ||
| 2024-05-29 | Pottage John C Jr Director | Grant or award | +20,000 | 55,000 | ||
| 2024-02-05 | Shukla Sath CEO and President | Sale 10b5-1 | −45,093 | $1.45 | $65K | 1,176,007 |
| 2024-02-02 | Keutzer Timothy Chief Operating Officer | Sale | −30,971 | $1.36 | $42K | 534,050 |
| 2024-02-02 | Mahadevia Ankit Director | Sale | −63,795 | $1.37 | $87K | 744,997 |
| 2024-02-02 | JOSEPH TAMARA L Chief Legal Officer | Sale | −30,906 | $1.37 | $42K | 531,615 |
| 2024-02-02 | HAMED KAMAL Chief Medical Officer | Sale | −28,075 | $1.37 | $38K | 788,117 |
| 2024-02-02 | Shukla Sath CEO and President | Sale 10b5-1 | −30,901 | $1.37 | $42K | 1,221,100 |
| 2024-02-01 | Keutzer Timothy Chief Operating Officer | Grant or award | +239,731 | 565,021 | ||
| 2024-02-01 | JOSEPH TAMARA L Chief Legal Officer | Grant or award | +239,731 | 562,521 | ||
| 2024-02-01 | HAMED KAMAL Chief Medical Officer | Grant or award | +239,731 | 816,192 | ||
| 2024-02-01 | Rajavelu Esther See Remarks | Grant or award | +119,866 | 419,866 |
Page 4 of 8 · 157 trades